LOGIN
TXA effective in reducing blood loss and transfusion in TKA vs. routine hemostasis
October 2015
TXA effective in reducing blood loss and transfusion in TKA vs. routine hemostasis
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:1
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial
Arch Orthop Trauma Surg. 2015 Jul;135(7):1017-25Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
150 patients undergoing primary total knee arthroplasty (TKA) were randomized to receive 1 g of topical tranexamic acid (TXA), 2 g of intravenous TXA, or routine hemostasis. The purpose of the study was to determine which TXA administration modality more effectively reduced total blood loss 24 post-surgery and the need for subsequent blood transfusions. Findings indicated that although a significa...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.